Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,674
archived clinical trials in
Skin Cancer

RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Great Falls Clinic, Llp
mi
from
Great Falls, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Great Falls Clinic, Llp
mi
from
Great Falls, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
St. Peter's Hospital
mi
from
Helena, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
St. Peter's Hospital
mi
from
Helena, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Kalispell Regional Medical Center
mi
from
Kalispell, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Kalispell Regional Medical Center
mi
from
Kalispell, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Glacier Oncology, PLLC
mi
from
Kalispell, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Glacier Oncology, PLLC
mi
from
Kalispell, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Montana Cancer Center
mi
from
Missoula, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Montana Cancer Center
mi
from
Missoula, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Winthrop University Hospital
mi
from
Mineola, NY
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Winthrop University Hospital
mi
from
Mineola, NY
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
James P. Wilmot Cancer Center, University of Rochester
mi
from
Rochester, NY
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
James P. Wilmot Cancer Center, University of Rochester
mi
from
Rochester, NY
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Wayne Memorial Hospital, Incorporated
mi
from
Goldsboro, NC
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Wayne Memorial Hospital, Incorporated
mi
from
Goldsboro, NC
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Pardee Memorial Hospital
mi
from
Hendersonville, NC
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Pardee Memorial Hospital
mi
from
Hendersonville, NC
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Mary Rutan Hospital
mi
from
Bellefontaine, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Mary Rutan Hospital
mi
from
Bellefontaine, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Adena Regional Medical Center
mi
from
Chillicothe, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Adena Regional Medical Center
mi
from
Chillicothe, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Taussig Cancer Center, Cleveland Clinic Foundation
mi
from
Cleveland, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Taussig Cancer Center, Cleveland Clinic Foundation
mi
from
Cleveland, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
CCOP, Central Illinois
mi
from
Springfield, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
CCOP, Central Illinois
mi
from
Springfield, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Grant Medical Center Cancer Care
mi
from
Columbus, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Grant Medical Center Cancer Care
mi
from
Columbus, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Ohio Health Research Institute / Riverside Methodist Hospital
mi
from
Columbus, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Ohio Health Research Institute / Riverside Methodist Hospital
mi
from
Columbus, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Mount Carmel West Hospital
mi
from
Columbus, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Mount Carmel West Hospital
mi
from
Columbus, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Doctors Hospital
mi
from
Columbus, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Doctors Hospital
mi
from
Columbus, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Good Samaritan Hospital - Dayton
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Good Samaritan Hospital - Dayton
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Grandview Hospital
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Grandview Hospital
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Samaritan North Cancer Care Center
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Samaritan North Cancer Care Center
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Dayton CCOP
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Dayton CCOP
mi
from
Dayton, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Grady Memorial Hospital
mi
from
Delaware, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Grady Memorial Hospital
mi
from
Delaware, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Blanchard Valley Medical Associates
mi
from
Findlay, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Blanchard Valley Medical Associates
mi
from
Findlay, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Middletown Regional Hospital
mi
from
Franklin, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Middletown Regional Hospital
mi
from
Franklin, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Wayne Hospital
mi
from
Greenville, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Wayne Hospital
mi
from
Greenville, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Kettering Health Network of Kettering Medical Center
mi
from
Kettering, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Kettering Health Network of Kettering Medical Center
mi
from
Kettering, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Fairfield Medical Center
mi
from
Lancaster, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Fairfield Medical Center
mi
from
Lancaster, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Knox Community Hospital
mi
from
Mount Vernon, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Knox Community Hospital
mi
from
Mount Vernon, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Community Hospital of Springfield and Clark County
mi
from
Springfield, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Community Hospital of Springfield and Clark County
mi
from
Springfield, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Upper Valley Medical Center
mi
from
Troy, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Upper Valley Medical Center
mi
from
Troy, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Mount Carmel St. Ann's Cancer Center
mi
from
Westerville, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Mount Carmel St. Ann's Cancer Center
mi
from
Westerville, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Clinton Memorial Hospital
mi
from
Wilmington, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Clinton Memorial Hospital
mi
from
Wilmington, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Genesis Healthcare System
mi
from
Zanesville, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Genesis Healthcare System
mi
from
Zanesville, OH
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Clackamas Radiation Oncology Center
mi
from
Clackamas, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Clackamas Radiation Oncology Center
mi
from
Clackamas, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Providence Newberg Medical Center
mi
from
Newberg, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Providence Newberg Medical Center
mi
from
Newberg, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Willamette Falls Hospital
mi
from
Oregon City, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Willamette Falls Hospital
mi
from
Oregon City, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Adventist Medical Center
mi
from
Portland, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Adventist Medical Center
mi
from
Portland, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Providence Portland Cancer Center
mi
from
Portland, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Providence Portland Cancer Center
mi
from
Portland, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Columbia River Oncology Program
mi
from
Portland, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Columbia River Oncology Program
mi
from
Portland, OR
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Providence St. Peter Hospital Regional Cancer Center
mi
from
Olympia, WA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Providence St. Peter Hospital Regional Cancer Center
mi
from
Olympia, WA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
AnMed Health Medical Center
mi
from
Anderson, SC
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
AnMed Health Medical Center
mi
from
Anderson, SC
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
McLeod Regional Medical Center
mi
from
Florence, SC
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
McLeod Regional Medical Center
mi
from
Florence, SC